83 Workers Laid Off: Impact on Como and Varese Commuters
- The pharmaceutical company Bioggio Pharma Manufacture SA (BPM),located in Canton Ticino,has announced it will cease production by August 31.
- The Bioggio-based pharmaceutical firm stated that despite efforts initiated in 2023 to find a financially enduring solution, the closure is now unavoidable.
- the closure represents a significant blow to the workforce, with a ample portion, reportedly 70%, being cross-border workers from the provinces of Como and Varese.The sudden decision left...
Bioggio Pharma Manufacture SA to Cease Production,Laying Off 80 Employees
Table of Contents
- Bioggio Pharma Manufacture SA to Cease Production,Laying Off 80 Employees
- Bioggio pharma Manufacture SA Closure: Yoru Questions Answered
- Key Questions About the Bioggio Pharma Manufacture SA Closure
- Why is Bioggio Pharma Manufacture SA closing?
- When will Bioggio Pharma Manufacture SA cease production?
- How many employees will be laid off due to the closure?
- What is the impact on cross-border workers?
- Where is Bioggio Pharma Manufacture SA located?
- What is the company’s UID?
- What actions are being taken to address the job losses?
- Understanding the Broader Context
- Summary of Key Details
- What Happens Next?
- Key Questions About the Bioggio Pharma Manufacture SA Closure
The pharmaceutical company Bioggio Pharma Manufacture SA (BPM),located in Canton Ticino,has announced it will cease production by August 31. this decision will result in the layoff of all 80 employees.
Unexpected Closure Proclamation
The Bioggio-based pharmaceutical firm stated that despite efforts initiated in 2023 to find a financially enduring solution, the closure is now unavoidable. The news came as a shock to the employees of Bioggio Pharma Manufacture SA.
Impact on Cross-Border Workers
the closure represents a significant blow to the workforce, with a ample portion, reportedly 70%, being cross-border workers from the provinces of Como and Varese.The sudden decision left employees dismayed after being summoned to a meeting where the drastic outcome was communicated.
Loss of Key Contract Cited
General Manager matthew Brabazon explained that the closure was primarily driven by the loss of a major contract for contract manufacturing. This loss has substantially impacted the financial viability of Bioggio pharma Manufacture SA.
According to Zefix.ch, Bioggio Pharma Manufacture SA, also known as ginsana AG and Ginsana Ltd., is located at Via Mulini 8, 6934 Bioggio. The company’s UID is CHE-103.274.646.
Legal and Union Involvement
Management has already contacted the legal office of the Labor section of Canton Ticino. Unions are currently exploring potential avenues for negotiation to safeguard at least some of the jobs. The situation remains uncertain, particularly for the numerous Lombard cross-border workers who face the prospect of sudden unemployment.
Future Outlook Uncertain
The future remains uncertain for the employees of Bioggio Pharma Manufacture SA as they face potential job losses. Further developments are awaited as unions and management engage in discussions.
the company’s registration details can be found under the ID CHE-103.274.646, as noted in the commercial register mutation.
key Takeaways
- Bioggio Pharma Manufacture SA will cease production by August 31.
- All 80 employees will be laid off.
- The closure is due to the loss of a major contract.
- Unions are seeking to negotiate and save jobs.
- Many affected employees are cross-border workers.
Bioggio pharma Manufacture SA Closure: Yoru Questions Answered
This article addresses the key questions surrounding the closure of Bioggio Pharma Manufacture SA (BPM) in canton Ticino, Switzerland, providing clarity on the reasons, impact, and potential next steps.
Key Questions About the Bioggio Pharma Manufacture SA Closure
Why is Bioggio Pharma Manufacture SA closing?
Bioggio Pharma Manufacture SA is ceasing production due to the loss of a major contract for contract manufacturing. According to General manager Matthew Brabazon, this loss has severely impacted the company’s financial stability, making the closure unavoidable despite efforts initiated in 2023 to find a sustainable solution.
When will Bioggio Pharma Manufacture SA cease production?
The company will cease production by August 31. This marks the final date of operations for the bioggio-based pharmaceutical firm.
How many employees will be laid off due to the closure?
The closure of Bioggio Pharma Manufacture SA will result in the layoff of all 80 employees.
What is the impact on cross-border workers?
The closure significantly impacts cross-border workers, who constitute approximately 70% of the company’s workforce. These employees primarily come from the provinces of Como and Varese (Lombardy, Italy) and face potential sudden unemployment.
Where is Bioggio Pharma Manufacture SA located?
Bioggio Pharma Manufacture SA is located at Via Mulini 8, 6934 Bioggio, in Canton Ticino, Switzerland. It is also known as Ginsana AG and Ginsana Ltd.
What is the company’s UID?
The company’s UID (Unternehmens-Identifikationsnummer, or Company Identification Number) is CHE-103.274.646. This can be used to find the company’s registration details in the Swiss commercial register (Zefix.ch).
What actions are being taken to address the job losses?
Management has contacted the legal office of the Labor section of Canton Ticino. Unions are currently involved and exploring potential avenues for negotiation to potentially safeguard at least some of the jobs. The situation is still uncertain.
Understanding the Broader Context
What is contract manufacturing and why is it vital?
Contract manufacturing involves a company outsourcing its manufacturing processes to a third-party manufacturer.This is a common practice in the pharmaceutical industry, allowing companies to focus on research, development, and marketing while relying on specialized manufacturers for production.The loss of a major contract in this area can have important financial repercussions for a company like Bioggio Pharma Manufacture SA.
What are the implications for the pharmaceutical sector in Ticino?
The closure of Bioggio Pharma Manufacture SA is a blow to the pharmaceutical sector in Ticino. It highlights the challenges faced by pharmaceutical manufacturers, notably those reliant on contract manufacturing.
Summary of Key Details
| Feature | Detail |
|————————–|———————————————–|
| Company Name | Bioggio Pharma Manufacture SA (BPM) |
| Location | Bioggio, Canton Ticino, Switzerland |
| Closure Date | August 31 |
| Reason for Closure | Loss of major contract manufacturing contract |
| Number of Layoffs | 80 |
| Impacted Workers | Including 70% cross-border workers |
| Company UID | CHE-103.274.646 |
| Union Involvement | Exploring negotiation avenues |
| Other Names | Ginsana AG, Ginsana Ltd. |
What Happens Next?
The future remains uncertain for the employees of Bioggio Pharma Manufacture SA. Further developments are awaited as unions and management engage in discussions to mitigate the impact of the closure. The situation is particularly challenging for the cross-border workers who face sudden unemployment and must navigate employment regulations in both Switzerland and their home countries.